1. The role of peroxiredoxins in cancer
    Arianna Nicolussi et al, 2017, Molecular and Clinical Oncology CrossRef
  2. Dual role of PRDX1 in redox-regulation and tumorigenesis: Past and future
    Xin Guan et al, 2024, Free Radical Biology and Medicine CrossRef
  3. Involvement of a 1-Cys Peroxiredoxin in Bacterial Virulence
    Gilberto Hideo Kaihami et al, 2014, PLoS Pathogens CrossRef
  4. Comprehensive analysis of the expression levels and prognostic values of PRDX family genes in glioma
    Monika Szeliga, 2022, Neurochemistry International CrossRef
  5. Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated
    Candelaria Bracalente et al, 2106, Oncotarget CrossRef
  6. Oxidative stress in thyroid carcinomas: biological and clinical significance
    Rabii Ameziane El Hassani et al, 2019, Endocrine-Related Cancer CrossRef
  7. Structural basis of peroxidase catalytic cycle of human Prdx6
    Rimpy Kaur Chowhan et al, 2020, Scientific Reports CrossRef

  8. PRDX1 is a Tumor Suppressor for Nasopharyngeal Carcinoma by Inhibiting PI3K/AKT/TRAF1 Signaling


    Hongmei Xiao et al, 2020, OncoTargets and Therapy CrossRef
  9. Peroxiredoxin 6 triggers melanoma cell growth by increasing arachidonic acid-dependent lipid signalling
    Alexandra Schmitt et al, 2015, Biochemical Journal CrossRef
  10. Analyses of antioxidant status and nucleotide alterations in genes encoding antioxidant enzymes in patients with benign and malignant thyroid disorders
    Nur Siti Fatimah Ramli et al, 2017, PeerJ CrossRef
  11. PRDX4 Potentially Predicts the Postoperative Outcome in Advanced Papillary Thyroid Carcinoma
    Yuki Takaoka et al, 2022, Endocrines CrossRef
  12. Emerging Role of Oxidative Stress on EGFR and OGG1-BER Cross-Regulation: Implications in Thyroid Physiopathology
    Carmelo Moscatello et al, 2022, Cells CrossRef
  13. A Ferroptosis-Related Prognostic Signature Based on Antitumor Immunity and Tumor Protein p53 Mutation Exploration for Guiding Treatment in Patients With Head and Neck Squamous Cell Carcinoma
    Xin Fan et al, 2021, Frontiers in Genetics CrossRef
  14. Changes in antioxidant status and DNA repair capacity are corroborated with molecular alterations in malignant thyroid tissue of patients with papillary thyroid cancer
    Zing Hong Eng et al, 2023, Frontiers in Molecular Biosciences CrossRef
  15. Peroxiredoxin 1 – an antioxidant enzyme in cancer
    Chenbo Ding et al, 2017, Journal of Cellular and Molecular Medicine CrossRef
  16. Hydrogen peroxide – production, fate and role in redox signaling of tumor cells
    Claudia Lennicke et al, 2015, Cell Communication and Signaling CrossRef
  17. Optimizing the identification of risk‐relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families
    Anna Coppa et al, 2018, Cancer Medicine CrossRef
  18. A novel BRCA2 splice variant identified in a young woman
    Arianna Nicolussi et al, 2020, Molecular Genetics & Genomic Medicine CrossRef
  19. Catalytic and Signaling Role of Peroxiredoxins in Carcinogenesis
    M. G. Sharapov et al, 2019, Biochemistry (Moscow) CrossRef
  20. Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy
    M.S. Petronek et al, 2021, Redox Biology CrossRef